Cybersecurity Authorized News Coverage
Pharmaceutical large Teva pays $450 million to settle allegations it violated the False Claims Act by fixing the prices of several generic drugs and by elevating the price of a a quantity of sclerosis remedy whereas masking Medicare recipients’ copays, civil prosecutors said Thursday. Declaring it “a great settlement,” a Delaware vice chancellor accredited on Thursday a near chart-topping, $125 million deal to finish stockholder challenges to Discovery Inc.’s $43 billion merger with AT&T in 2022, an amount eclipsed solely by a $148.2 million pretrial deal in a 2016 case. A hospital operator’s purported $4 million …
